Azithromycin has no benefit for patients with severe COVID-19, RECOVERY trial data suggest

0
134

[ad_1]

The antibiotic azithromycin has no meaningful clinical benefit for patients who are hospitalised with severe COVID-19, a preliminary analysis of data from the Randomised Evaluation of COVID-19 Therapy trial has found.

[ad_2]

Source link

Share and Enjoy !

0Shares
0 0